Abstract
The lung is a point of intimate contact of the host with its environment and as such is a key point of interaction between animals and microbes. A range of host defence mechanisms exists to protect the lung from infection. These defence mechanisms include physical defences such as the filtration of air and the mucociliary escalator as well as the innate immune mechanisms such as the alveolar macrophage. The activity of these cells is augmented by the presence of various opsonins within the lung, including complement components and immunoglobulins. The inflammatory response and specific immune response in the lung are controlled by a range of cytokines and other immune mediators. To cause disease an invading pathogen must be able to subvert these normal defences.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gross GN, Rehm SR, Pierce AK (1978) The effect of complement depletion on lung clearance of bacteria. J Clin Invest 21: 373–378
Robertson J, Cladwell JR, Castle JR, Waldman RH (1976) Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol 117: 900–903
Coonrod JD, Yoneda K (1981) Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae. Rev Infect Dis 3: 310–322
Heidbrink PJ, Toews GB, Gross GN, Pierce AK (1982) Mechanisms of complement mediated clearance of baccteria from the murine lung. Am Rev Respir Dis 125: 517–520
Coonrod JD, Yoneda K (1982) Comparative role of complement in pneumococcal and Staphylococcal pneumonia. Infect Immun 37: 1270–1277
Wood WB Jr (1951) Studies on the cellular immunology of acute bacterial infections. Harvey Lect 47: 72–98
Bakker-Woudenberg IAJM, deJong-Hoenderop JYT, Michel MF (1979) Efficacy of antimicrobial therapy in rat pneumonia: effects of impaired phagocytosis. Infect Immun 25: 366–375
Guckian JC, Christiansen GD, Fine DP (1980) The role of opsonins in recovery from experimental pneumococcal pneumonia. J Infect Dis 142: 175–190
Botto M, Fong KY, So AE, Rudge A, Walport MJ (1990) Molecular basis of hereditary C3 deficiency. J Clin Invest 86: 1158–1163
Alper CA, Abramson N, Johnson RB Jr, Jandel JH, Rosen FS (1970) Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N EnglJ Med 282: 349–354
Homann C, Vanning K, Hogasen K, Mollnes TE, Gradudal N, Thomsen AC, Garrod P (1997) Aquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 40: 544–549
Auerbach HS, Burger R, Dodds A, Colten HR (1990) Molecular basis of complement C3 deficiency in guinea pigs. J Clin Invest 86: 96–106
Winkelstein JA, Cork LC, Griffin DE, Adams RJ, Price DL (1981) Genetically determined deficiency of the third component of complement in the dog. Science 212: 1169–1173
O’Neil KM, Ochs HD, Heller SR, Cork LC, Morris JM, Winkelstein JA (1988) Role of C3 in humoral immunity. J Immunol 140: 1939–1945
Ameratunga R, Winkelstein JA, Brody L, Binns M, Cork LC, Colombani P, Valle D (1998) Molecular analysis of the third component of canine complement (C3) and identification of the mutation responsible for hereditary canine C3 deficiency. J Immunol 160: 2824–2830
Toews GB, Vial WC (1984) The role of C5 in polymorphonuclear leukocyte recritment in response to Streptococcuspneumoniae. Annu Rev Respir Dis 129: 82–86
Hopken UE, Lu B, Gerard NP, Gerard C (1996) The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383: 86–89
Anderson DC, Schmalsteig FC, Kohl S, Arnaout MA, Hughes BJ, Towse MF, Bafoney GJ, Brinkley BR, Dickey WD, Abramson JS et al. (1984) Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoprotein (gpl38): common relationship to diminished cell adherence. J Clin Invest 74: 546–555
Arnaout MA, Pitt J, Cohen HJ, Melamed J, Rosen FS, Colten HR (1982) Deficiency in a granulocyte-membrane glycoprotein (gpl50) in a boy with recurrent bacterial infections. N EnglJ Med 305: 693–699
Bowen TJ, Ochs HD, Altman LC, Price HC, van Epps DE, Brautigan DC, Rosin RE, Perkins WD, Babior BM, Klebanoff SJ et al. (1982) Severe recurrent bacterial infections associated with defective adherance and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr 101: 932–940
Crowley CA, Curnutte JT, Rosin RE, Andre-Schwartz J, Gallin JI, Kiemphar M, Snyderman R, Southwick F, Stossel TP, Babior BM (1980) An inherited abnormality of neutrophil adhesion: its genetic transmission and its association with the missing protein. N Engl J Med 302: 1163–1168
Oxelius V-A (1974) Chronic infections in a family with hereditary deficiency of IgG2 and IgG4. Clin Exp Immunol 17: 19–24
Bjorkander J, Bake B, Oxelius V-A, Hanson LA (1985) Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. N Engl J Med 313: 720–724
Morgan KL, Hussein AM, Newby TJ, Bourne FJ (1980) Quantification and origin of the immunoglobulins in procine respiratory tract secretions. Immunology 41: 729–736
Merrill WW, Naegel GP, Olchowski JJ, Reynolds HY (1985) Immunoglobulin subclass proteins in serum and lavage fluid of normal subjects: quantitation and comparison with immunoglobulin A and E. Am Rev Respir Dis 131: 584–587
Jakab GJ (1976) Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms. Infect Immun 14: 389–398
Dunn MM, Toews GB, Hart D, Pierce AK (1985) The effects of systemic immunization on pulmonary clearance of Pseudomonas aeruginosa. Am Rev Respir Dis 131: 426–431
Hansen EJ, Hart DA, McGehee JL (1988) Immune enhancement of pulmonary clearance of nontypable Haemophilus influenzae. Infect Immun 56: 182–190
Pennington JE, Hickey WF, Blackwood LL (1981) Active immunization with lipopolysac-charide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs. J Clin Invest 68: 1140–1148
Toews GB, Hart DA, Hansen EJ (1985) Effect of systemic immunisation on pulmonary clearance of Haemophilus influenzae type b. Infect Immun 48: 343–349
Hill SL, Mitchell JL, Burnett D, Stockley RA (1998) IgG subclasses in sputum from patients with bronchiectasis. Thorax 53: 463–468
Uderdown BJ, Schiff JM (1986) Immunoglobulin A: strategic defence at the mucosal surface:. Annu Rev Immunol 4: 389–417
a Orga PL, Karzou DT, Righthand F, MacGillivray M (1968) Immunoglobulin responses in serum and secretions after immunisation with live and inactivated polio vaccine and natural infection. N Engl J Med 279: 893–900
b Plant AG (1983) The IgA proteases of pathogenic bacteria. Ann Rev Microbiol 37: 603–622
Kitamura D, Roes J, Kuhm R, Rajewsky K (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423–426
Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 11: 7380–73
Hogan B, Constantini F, Lacy E (1986) Manipulating the mouse embryo: A laboratory manual. Cold Spring Harbor, New York
Field LJ (1993) Transgenic mice in cardiovascular research. Annu Re Physiol 55: 97–114
Gordon JW, Ruddle FH (1983) Gene transfer into mouse embryos: production of transgenic mice by pronuclear infection. Methods Enzymol 101: 411–433
Ho Y-S (1994) Transgenic models for the study of lung biology and disease. Am J Physiol 10: L319–L353
Friis-Christiansen P, Thiel S, Svehag S-E, Dessau R, Svendsen R, Andersen O, Lauren SB, Jensenius JC (1990) In vivo and in vitro antibacterial activity of conglutinin, a mammalian plant lectin. Scand J Immunol 31: 453–460
Ezekowitz RAB, Kuhlman M, Groopman JE, Byrn RA (1989) A human-serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 169: 185–196
McNeeley TB, Coonrod JD (1993) Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J Infect Dis 167: 91–97
Kuan SF, Rust K, Crouch E (1992) Interactions of surfactant protein D with bacterial lipo-polysaccharide. J Clin Invest 90: 97–106
Super M, Thiel JS, Lu J, Levinsky RJ, Turner MW (1989) Association of low levels of man-nan binding protein with a common defect of opsonisation. Lancet ii: 1236–12
Baughman RP, Sternberg RI, Hull W, Buchsbaum JA, Whitsett J (1993) Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis 147: 653–657
LeVine AM, Lotze A, Stanley S, Stroud C, O’Donnell R, Whitsett J, Pollack MM (1996) Surfactant content in children with inflammatory lung disease. Crit Care Med 24: 1062–1067
Wispe JR, Clark JC, Warner BB, Fajardo D, Hull WE, Holtzman RB, Whitsett JA (1990) Tumor necrosis factor alpha inhibitx expression of pulmonary surfactant protein. J Clin Invest 86: 1954–1960
Pison U, Wright JR, Hawgood S (1992) Specific binding of surfactant protein apoprotein SP-A to rat alveolar macrophages. Am J Physiol 262: L412–L417
Manz-Keinke H, Plattner H, Schlepper-Schafer J (1992) Lung surfactant protein A (SP-A) enhances serum independent phagocytosis of bacteria by alveolar macrophages. Eur J Cell Biol 57: 95–100
Van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, van Golde LMG (1990) Pulmonary surfactant protein A enhances the host defence mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 2: 91–98
LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR (1997) Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 158: 4336–4340
Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC (1995) Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both inate and aquired immunity. Proc Natl Acad Sci USA 92: 11490–11494
Williams DM, Grubbs BG, Pack E, Kelly K, Rank RG (1997) Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis. Infect Immun 65: 2876–2882
Mombaerts P, Clarke AR, Hooper ML, Tonegawa S (1991) Creation of a large genomic deletion at the T cell antigen receptor beta-subunit locus in mouse embryonic stem-cells by gene targetting. Proc Natl Acad Sci USA 88: 3084–3087
Itohara S, Mombaerts P, Lafaille J, Iacomi J, Nelson J, Clarke AR, Hooper ML, Farr A, Tone-gawa S (1993) T-cell receptor delta-gene mutant mice-independet generation of alpha-beta T-cells and programmed rearrangements of gamma-delta TCR genes. Cell 72: 337–348
Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH (1991) Depletion of CD4+ T cells in major histocompatability complex II-deficient mice. Science 253: 1417–1420
Koller BH, Smithies O (1989) Inactivating the β-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci USA 86: 8932–8935
Kaufmann SHE, Ladel CH (1994) Application of knock-out mice to the experimental analysis of infections with bacteria and protozoa. Trends Microbiol 2: 235–242
Flynn JL, Goldstein MM, Triebold KJ, Koller BBRB (1992) Major histocompatiability complex class-I restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl AcadSci USA 89: 12013–12017
Laochumroomvorapong P, Wang J, Chau-Ching L, Ye W, Moreira AL, Elkon KB, Freedman VH, Kaplan G (1997) Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the control of early mycobacterial infection in mice. Infect Immun 65: 127–132
Flesch IE, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H, Kaufmann SHE (1995) Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon y and tumor necrosis factor α. J Exp Med 181: 1615–1621
Fulton SA, Johnson JM, Wolf SF, Sieburth DS, Bloom WH (1996) Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: Role of phagocytosis. Infect Immun 64: 2523–2531
Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM (1995) The role of interleukin-12 in aquired immunity to Mycobacterium tuberculosis infection. Immunology 84: 423–432
Vordmeier HM, Kenkataprasad N, Harris DP, Ivanyi J (1996) Increase of tuberculous infection in the organs of B-cell-deficient mice. Clin Exp Immunol 106: 312–316
Rubins JB, Pomeroy C (1997) Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun 65: 2975–2977
Taylor-Robinson AW, Phillips RS (1996) Reconstitution of B-cell depleted mice with B-cells restores the Th2-type immune response during Plasmodium chabaudi chaubdi infection. Infect Immun 64: 366–370
Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM (1993) Disseminated tuberculosis in interferon-gamma gene-disrupted mice. J Exp Med 178: 2243–2247
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Mitchell, T.J. (1999). Genetic Models of Bacterial Lung Infection. In: Stockley, R.A. (eds) Molecular Biology of the Lung. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8831-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8831-8_8
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9791-4
Online ISBN: 978-3-0348-8831-8
eBook Packages: Springer Book Archive